Skip to main navigation menu Skip to main content Skip to site footer

Vol. 24 No. 3 (2020)

Artículos de Revisión

Progress in female fertility protection and preservation

  • Pooja Dhungel
    • ,
  • Muqing Gu
    • ,
  • Xiangyan Ruan
    • ,
  • Alfred O. Mueck

DOI: https://doi.org/10.23878/medicina.v24i3.1208

PDF EPUB

Abstract

Survival rate of cancer patients is increasing in recent years due to treatments like radiotherapy and chemotherapy. This treatment is also impairing the reproductive ability of women, causing premature ovarian failure leading to early infertility. Fertility preservation in women has appeared to be an important issue but with advancement in assisted reproductive technologies there is a possibility of preserving fertility in cancer and non-cancer patients. Current fertility preservation options are traditional methods like embryo and oocyte cryopreservation with new technology like ovarian tissue cryopreservation and transplantation. Oocyte cryopreservation is used for women with benign disease, women seeking fertility for personal, religious and legal reasons. For prepubertal girls and patients who cannot delay anticancer treatments to preserve fertility and ovarian endocrine function, ovarian tissue cryopreservation is the one and only option. This paper will summarize the main methods and progress of female fertility protection and preservation.

Keywords

embryo cryopreservation, oocyte cryopreservation, ovarian tissue cryopreservation and transplantation

References

  1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249.
  2. Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022-1033.
  3. Takahashi N, Harada M, Oi N, et al. Preclinical validation of the new vitrification device possessing a feature of absorbing excess vitrification solution for the cryopreservation of human embryos. J Obstet Gynaecol Res. 2020;46(2):302-309.
  4. Spears N, Lopes F, Stefansdottir A, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019;25(6):673-693.
  5. Joshi S, Savani BN, Chow EJ, et al. Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2014;49(4):477-484.
  6. Horton J, Sterrenburg M, Lane S, Maheshwari A, Li TC, Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(5):592-632.
  7. Giri R, Vincent AJ. Prevalence and Risk Factors of Premature Ovarian Insufficiency/Early Menopause. Semin Reprod Med. 2020;38(4-05):237-246.
  8. Cheng J, Ruan X, Du J, et al. . Ovarian tissue cryopreservation for a 3-year-old girl with Mosaic Turner syndrome in China: First case report and literature review. Front Endocrinol (Lausanne). 2022;13:959912.
  9. Mohammad NS, Nazli R, Zafar H, Fatima S. Effects of lipid based Multiple Micronutrients Supplement on the birth outcome of underweight pre-eclamptic women: A randomized clinical trial. Pak J Med Sci. 2022;38(1):219-226.
  10. Population Census Office of the State Council, population statistics Department of National Bureau of statistics of China, 2021. Acceso eletrónico: http://www.stats.gov.cn/english/PressRelease/202105/t20210510_1817185.html
  11. Insogna IG, Lanes A, Lee MS, Ginsburg ES, Fox JH. Association of Fresh Embryo Transfers Compared with Cryopreserved-Thawed Embryo Transfers With Live Birth Rate Among Women Undergoing Assisted Reproduction Using Freshly Retrieved Donor Oocytes. JAMA. 2021;325(2):156-163.
  12. Cobo A, García-Velasco J, Domingo J, Pellicer A, Remohí J. Elective and Onco-fertility preservation: factors related to IVF outcomes. Hum Reprod. 2018;33(12):2222-2231.
  13. Druckenmiller S, Goldman KN, Labella PA, Fino ME, Bazzocchi A, Noyes N. Successful Oocyte Cryopreservation in Reproductive-Aged Cancer Survivors. Obstet Gynecol. 2016;127(3):474-480.
  14. Santos ML, Pais AS, Almeida Santos T. Fertility preservation in ovarian cancer patients. Gynecol Endocrinol. 2021;37(6):483-489.
  15. Dolmans MM, Donnez J. Fertility preservation in women for medical and social reasons: Oocytes vs ovarian tissue. Best Pract Res Clin Obstet Gynaecol. 2021;70:63-80.
  16. Dolmans MM, von Wolff M, Poirot C, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. Fertil Steril. 2021;115(5):1102-1115.
  17. Ruan X, Cheng J, Du J, et al. Analysis of Fertility Preservation by Ovarian Tissue Cryopreservation in Pediatric Children in China. Front Endocrinol (Lausanne). 2022;13:930786.
  18. Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364(9443):1405-1410.
  19. Dolmans MM, Falcone T, Patrizio P. Importance of patient selection to analyze in vitro fertilization outcome with transplanted cryopreserved ovarian tissue. Fertil Steril. 2020;114(2):279-280.
  20. Ruan X, Du J, Korell M, et al. Case report of the first successful cryopreserved ovarian tissue retransplantation in China. Climacteric. 2018;21(6):613-616.
  21. Ruan X, Cheng J, Korell M, et al. Ovarian tissue cryopreservation and transplantation prevents iatrogenic premature ovarian insufficiency: first 10 cases in China. Climacteric. 2020;23(6):574-580.
  22. Ruan X, Cui Y, Du J, et al. Randomized study to prove the quality of human ovarian tissue cryopreservation by xenotransplantation into mice. J Ovarian Res. 2019;12(1):46.
  23. Cheng J, Ruan X, Du J, et al. Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: a case report. J Ovarian Res. 2021;14(1):176.
  24. Ruan X, Du J, Lu D, et al. First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency. Climacteric. 2022;25(4):421-424.
  25. Ruan X, Cheng J, Du J, et al. Analysis of Fertility Preservation by Ovarian Tissue Cryopreservation in Pediatric Children in China. Front Endocrinol (Lausanne). 2022;13:930786.
  26. Khattak H, Malhas R, Craciunas L, et al. Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis. Hum Reprod Update. 2022;28(3):400-416.
  27. Ruan X. Chinese society of gynecological endocrinology affiliated to the international society of gynecological endocrinology guideline for ovarian tissue cryopreservation and transplantation. Gynecol Endocrinol. 2018;34(12):1005–1010.
  28. Burns KC, Hoefgen H, Strine A, Dasgupta R. Fertility preservation options in pediatric and adolescent patients with cancer. Cancer. 2018;124(9):1867-1876.
  29. AIOM. Linee guida per la preservazione della fertilità nei pazienti oncologici. Acceso eletrónico en: https://www.aiom.it/. Italian Association of Medical Oncology (AIOM), 2020.
  30. Brancati S, Gozzo L, Longo L, Vitale DC, Russo G, Drago F. Fertility Preservation in Female Pediatric Patients with Cancer: A Clinical and Regulatory Issue. Front Oncol. 2021;11:641450.
  31. Lambertini M, Peccatori FA, Demeestere I, et al.; ESMO Guidelines Committee. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†. Ann Oncol. 2020;31(12):1664-1678.

How to Cite

1.
Dhungel P, Gu M, Ruan X, Mueck AO. Progress in female fertility protection and preservation. Rev. Med. UCSG [Internet]. 2023 Sep. 11 [cited 2025 Apr. 16];24(3):13-20. Available from: https://editorial.ucsg.edu.ec/medicina/index.php/ucsg-medicina/article/view/1208

Download Citation

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.